International oncology drug approvals for multiregional or single-country clinical trials: A systematic review

BACKGROUND: Cancer remains one of the most common causes of morbidity and mortality worldwide. Multiregional (MRCTs) and single-country clinical trials are two common approaches to support new oncology drug approvals internationally. However, systematic reviews comparing MRCTs with single-country tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min, Onakpoya, Igho, Rupalla, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798114/
https://www.ncbi.nlm.nih.gov/pubmed/36590932
http://dx.doi.org/10.3389/fmed.2022.1084980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798114/
https://www.ncbi.nlm.nih.gov/pubmed/36590932
http://dx.doi.org/10.3389/fmed.2022.1084980

Ejemplares similares